Common use of Following Sanofi Participation Election Effective Date Clause in Contracts

Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 1, [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the [***].

Appears in 3 contracts

Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.), Collaboration and License Agreement (Kymera Therapeutics, Inc.), Collaboration and License Agreement (Kymera Therapeutics, Inc.)

AutoNDA by SimpleDocs

Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 1[***], [***] will have the first right (but not the obligation) to Prosecute and Maintain the all [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the such [***].

Appears in 2 contracts

Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.), Collaboration and License Agreement (Kymera Therapeutics, Inc.)

Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 1[***], [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the such [***].

Appears in 2 contracts

Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.), Collaboration and License Agreement (Kymera Therapeutics, Inc.)

Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 12, [***] will have the first right (but not the obligation) to Prosecute and Maintain the all [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the such [***].

Appears in 1 contract

Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.)

Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 1[***], [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the [***].

Appears in 1 contract

Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.)

Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 1[***], [***] will have the first right (but not the 110 CONFIDENTIAL obligation) to Prosecute and Maintain the [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the such [***].

Appears in 1 contract

Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.)

AutoNDA by SimpleDocs

Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 1[***], [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the [***].. 109 12.2.5 [***]. Subject to Section 12.2.4, the Parties will divide responsibility for the Prosecution and Maintenance of [***], other than [***], as follows:

Appears in 1 contract

Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.)

Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 1[***], [***] will have the first right (but not the obligation) to Prosecute and Maintain the all [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the such [***].

Appears in 1 contract

Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.)

Following Sanofi Participation Election Effective Date. (i) [***]. During the Sanofi Participation Term (if any) for Collaboration Target 1[***], [***] will have the first right (but not the obligation) to Prosecute and Maintain the [***]. [***] will have the right to review and comment on the Prosecution and Maintenance of the [***].

Appears in 1 contract

Samples: Collaboration and License Agreement (Kymera Therapeutics, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.